Alert: Because flu cases are on the rise, children 12 and younger will be restricted from visiting hospitals and certain inpatient facilities. Learn more.

Research and Clinical Trials

Brief Description  
The purpose of this study is to test the safety and effectiveness of the study drug sitagliptin (Januvia) in patients with type 2 diabetes and cardiovascular disease.
Who may be Eligible  
Men and women 50 years and older with a history of type 2 diabetes and cardiovascular disease.
IRB Number  
Principal Investigator  
Dulin, Michael

For More Information, Contact  Kelry  R, Preston
Phone:  (704) 304-7145  Fax:  (704) 304-7102  
Email:  kelry.preston@carolinashealthcare.org
Address:2001 Vail Avenue Suite 400 Mercy Medical Plaza Charlotte, NC 28207